Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)
201.11
-4.29
(-2.09%)
Streaming Delayed Price
Updated: 2:17 PM EDT, Aug 25, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 192,027 |
| Open | 207.58 |
| Bid (Size) | 201.00 (400) |
| Ask (Size) | 201.43 (100) |
| Prev. Close | 205.40 |
| Today's Range | 201.00 - 209.53 |
| 52wk Range | 112.90 - 260.19 |
| Shares Outstanding | 47,190,970 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Axsome Therapeutics Q2 Earnings Call Highlights ↗
August 10, 2026
3 Under-the-Radar Stocks to Buy and Hold ↗
July 10, 2026
Better Growth Buy: Axsome vs Revolution Medicines ↗
July 09, 2026
3 Under-the-Radar Stocks to Buy and Hold for a Decade ↗
June 16, 2026
Frequently Asked Questions
Is Axsome Therapeutics, Inc. - Common Stock publicly traded?
Yes, Axsome Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Axsome Therapeutics, Inc. - Common Stock trade on?
Axsome Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Axsome Therapeutics, Inc. - Common Stock?
The ticker symbol for Axsome Therapeutics, Inc. - Common Stock is AXSM on the Nasdaq Stock Market
What is the current price of Axsome Therapeutics, Inc. - Common Stock?
The current price of Axsome Therapeutics, Inc. - Common Stock is 201.11
When was Axsome Therapeutics, Inc. - Common Stock last traded?
The last trade of Axsome Therapeutics, Inc. - Common Stock was at 08/25/26 02:17 PM ET
What is the market capitalization of Axsome Therapeutics, Inc. - Common Stock?
The market capitalization of Axsome Therapeutics, Inc. - Common Stock is 9.49B
How many shares of Axsome Therapeutics, Inc. - Common Stock are outstanding?
Axsome Therapeutics, Inc. - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.